BioSpace News Archive

Priority Review for BLA submission was granted by U.S. FDA for tafasitamab in combination with lenalidomide for relapsed/refractory diffuse large B cell lymphoma (r/r DLBCL) based on positive primary analysis data of L-MIND and Re-MIND studies

GeoVax Labs, Inc. provided an update on its development of a vaccine for prevention/control of novel coronavirus disease caused by SARS-Cov-2 coronavirus.

Heidelberg Pharma AG published its financial results and annual report for fiscal year 2019 and its outlook for 2020.

Company announces one-time bonus plan, as well as thousands of employment opportunities as Walgreens continues COVID-19 response efforts

In response to the COVID-19 pandemic, Gladstone scientists have rapidly pivoted the focus of their research labs to the novel virus, SARS-CoV-2.

In response to the calls for personal protective equipment for healthcare workers and other front-line responders battling the COVID-19 pandemic, Merck & Co., Inc., known as MSD outside the U.S. and Canada, announced it has provided a half a million personal protective masks to New York City for use as part of urgent efforts to address the outbreak in New York.

Liminal BioSciences Inc., a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases related to fibrosis, including respiratory, liver and kidney diseases that have high unmet medical need, commented on the impact of the current COVID-19 pandemic on its operations.

CMAB Biopharma Inc., has continued to monitor the development of the COVID-19 pandemic and has taken proactive measures to primarily protect the health of our employees worldwide.

UCSF Health, Northwell Health, UNC Health and other systems using Conversa’s virtual care and communication platform to triage people in their communities, manage patients, and screen healthcare workers

As part of the U.S. Food and Drug Administration’s ongoing efforts to address the coronavirus pandemic, the agency issued a new guidance to sponsors and healthcare providers regarding certain Risk Evaluation and Mitigation Strategy -required testing during this time.